Institut National de la Sante et de la Recherche Medicale


An antibody-based drug for multiple sclerosis

Inserm Unit U919, directed by Prof. Denis Vivien ("Serine Proteases and Physiopathology of the Neurovascular Unit") has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed ...


Skin cancer: A team synthesizes new drugs with surprising powers

Finding new, more effective and personalised treatments for cancer is the challenge of many researchers. A challenge that has been successfully met by a team from Inserm led by Stéphane Rocchi (Inserm Unit 1065, "Mediterranean ...

Medical research

The origin of heart dysfunctions in myotonic dystrophy identified

An international team, including researchers in France at Inserm, CNRS and the University of Strasbourg, brought together at IGBMC is lifting the veil on the molecular mechanisms causing heart dysfunctions in myotonic dystrophy, ...

Diseases, Conditions, Syndromes

New scientific evidence of sexual transmission of the Zika virus

A study by researchers from Inserm, the Paris Public Hospitals (Bichat Hospital, AP-HP), Aix-Marseille University, and the National Reference Centre for Arboviruses confirms that the ZIKA virus can be transmitted sexually. ...


An invisible system to rescue the heart

Heart failure affects over one million people in France. Although the blood system is the first to have been explored for the purpose of improving heart function, a study by Inserm has revealed the potential of a secondary ...

Psychology & Psychiatry

Treating depressive symptoms at their roots

A wide range of compounds is on the market to ameliorate depressive symptoms. However, their efficiency is achieved only after long periods of treatment and not in all patients. Inserm researchers identified early cellular ...

page 2 from 9